Techcyte Secures Patent to Increase Detection of Cancer in Pap Smears
The U.S. Patent Office has awarded a patent to Techcyte for automatically detecting objects in pap smears using hidden features and auxiliary ground truth.
Techcyte Secures Patent to Increase Detection of Cancer in Pap Smears
Techcyte, a leading developer of AI-based image analysis solutions, announced today that the U.S. Patent and Trademark Office has awarded a patent to automatically detect objects in microscopy slides using hidden features and auxiliary ground truth.
“The initial use of this technology is to identify precancerous and cancerous cells, along with other diagnostically important organisms, in pap smears.” said Michael Murdock, a machine learning engineer at Techcyte. “The technology in this patent will help save women’s lives throughout the world and can be used to improve other algorithms being developed at Techcyte.”
Techcyte is using AI-based image analysis to help cytotechnicians read pap smears more quickly, easily, and accurately than the existing systems on the market. By combining the strengths of an AI algorithm’s ability to quickly analyze 100% of a liquid-based slide and a cytotechnicians enhanced ability to confirm the proposed atypical cells, Techcyte’s solution increases accuracy while decreasing the time and cost to read each pap smear.
“Several sites around the world are performing clinical trials of Techcyte’s new digital cervical cytology solution,” said Rob Fotheringham, cervical cytology product manager at Techcyte. “Techcyte’s solution analyzes a liquid-based cervical cytology slide and proposes the most atypical cells, which are then quickly confirmed by a cytotechnician.”
###
About Techcyte
Headquartered in Lindon, Utah, Techcyte, Inc. was founded in 2013 and is the world leader in AI-based cellular digital diagnostics. Techcyte's use of deep machine learning to perform automated analysis of whole slide microscopy images is revolutionizing digital diagnostics in research, biopharma, environmental monitoring, and human and animal health. Visit www.techcyte.com for more information. Techcyte’s digital cytology solution is for Research Use Only in the United States.
Techcyte Media Contact:
Ben Cahoon, 801-980-0414, ben.cahoon@techcyte.com
Ben Cahoon
Techcyte, Inc.
+1 801-980-0414
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
